🇺🇸 FDA
Patent

US 10799596

Pyrrolobenzodiazepine-antibody conjugates

granted A61KA61K31/5517A61K39/001119

Quick answer

US patent 10799596 (Pyrrolobenzodiazepine-antibody conjugates) held by ADC THERAPEUTICS SA expires Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ADC THERAPEUTICS SA
Grant date
Tue Oct 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/5517, A61K39/001119, A61K45/06, A61K47/68035